Literature DB >> 25857495

Application of IS1311 locus 2 PCR-REA assay for the specific detection of 'Bison type' Mycobacterium avium subspecies paratuberculosis isolates of Indian origin.

Ajay Vir Singh, Devendra Singh Chauhan1, Abhinendra Singh, Pravin Kumar Singh, Jagdip Singh Sohal, Shoor Vir Singh.   

Abstract

BACKGROUND &
OBJECTIVES: Of the three major genotypes of Mycobacterium avium subspecies paratuberculosis (MAP), 'Bison type' is most prevalent genotype in the domestic livestock species of the country, and has also been recovered from patients suffering from Crohn's disease. Recently, a new assay based on IS1311 locus 2 PCR- restriction endonuclease analysis (REA) was designed to distinguish between 'Indian Bison type' and non-Indian genotypes. The present study investigated discriminatory potential of this new assay while screening of a panel of MAP isolates of diverse genotypes and from different geographical regions.
METHODS: A total of 53 mycobacterial isolates (41 MAP and 12 mycobacterium other than MAP), three MAP genomic DNA and 36 MAP positive faecal DNA samples from different livestock species (cattle, buffaloes, goat, sheep and bison) and geographical regions (India, Canada, USA, Spain and Portugal) were included in the study. The extracted DNA samples (n=92) were analyzed for the presence of MAP specific sequences (IS900, ISMav 2 and HspX) using PCR. DNA samples were further subjected to genotype differentiation using IS1311 PCR-REA and IS1311 L2 PCR-REA methods.
RESULTS: All the DNA samples (except DNA from non-MAP mycobacterial isolates) were positive for all the three MAP specific sequences based PCRs. IS1311 PCR-REA showed that MAP DNA samples of Indian origin belonged to 'Bison type'. Whereas, of the total 19 non-Indian MAP DNA samples, 2, 15 and 2 were genotyped as 'Bison type', 'Cattle type' and 'Sheep type', respectively. IS1311 L2 PCR-REA method showed different restriction profiles of 'Bison type' genotype as compared to non-Indian DNA samples. INTERPRETATION &
CONCLUSIONS: IS1311 L2 PCR-REA method successfully discriminated 'Indian Bison type' from other non-Indian genotypes and showed potential to be future epidemiological tool and for genotyping of MAP isolates.

Entities:  

Mesh:

Year:  2015        PMID: 25857495      PMCID: PMC4405941          DOI: 10.4103/0971-5916.154497

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


Mycobacterium avium subspecies paratuberculosis (MAP) is a cause of chronic granulomatous enteritis and lymphadinits (paratuberculosis or Johne's disease) in different species of animals1 including primates2. Johne's disease (JD) is responsible for inflicting huge economic losses to the livestock industry worldwide due to reduced milk production, increased premature culling and mortality and reduced fertility3. MAP-infected animals (sub-clinical and clinical) shed live bacilli in faeces and milk, thereby increasing the risk of transmission to newborn and other susceptible animals. Recently MAP has also been shown to be associated with Crohn's disease45 in human beings. MAP escapes standard pasteurization temperatures, and, therefore, presence of live MAP bacilli in the milk supplies is of great concern and poses potential risk to human population67. Control of MAP infection is the priority of developed countries to secure animal productivity and to reduce chances of human exposure. Inspite of the availability of sensitive tests89, ‘Test and cull’ method is not effective for the control of disease in livestock herds/flocks. Vaccination is considered as the method of choice for the control of JD in animals1011. However, efficacy of vaccines depends on the genotype of candidate strain used1112. Therefore, knowledge of the genotypes infecting domestic livestock species is critical for designing disease control strategies. Based on IS1311 polymerase chain reaction-restriction endonuclease analysis (PCR-REA) method, MAP isolates have been grouped into three genetically distinct genotypes (’Cattle type’, ‘Sheep type’ and ‘Bison type)1314. Studies reported host preferences of these MAP geno-groups, however, host adaptation is not absolute and inter-species sharing of MAP genotypes has been reported15. ‘Bison type’ genotype was first reported from wild bison of Montana, USA13, and later similar genotypes have been reported as major genotypes infecting domestic livestock, wild ruminants and human population in India16. Recently, ‘Bison type’ genotype has also been reported from other regions of Asia (Korea)17 and Africa (Uganda)18. We have earlier identified genomic variations in terms of genetic rearrangements, in-del polymorphisms and locus polymorphisms in ‘Bison type’ genotype of Indian origin when compared with genotypes reported from other parts of the world1920. Therefore, new nomenclature ‘Indian Bison type’ was assigned to ‘native Bison type’ genotype20. Another molecular signature (sequence variations of native genotype) was deletion of two base pairs (TG) at 64th and 65th positions of IS1311 element particularly at locus 2 as compared to non-Indian isolates1920. Taking the advantage of this molecular signature, a new IS1311 locus 2 specific PCR-REA (IS1311 L2 PCR-REA) assay was optimized for discrimination of ‘Indian Bison type’ from other isolates21. However, validation of this newly optimized assay was not done on a large panel of MAP isolates from different geographical regions of the world. The present study was carried out to investigate applicability of IS1311 L2 PCR-REA assay on samples of diverse genotypes (Cattle type, Sheep type and Bison type) and different geographical regions (India, Canada, USA, Spain and Portugal).

Material & Methods

A total of 53 mycobacterial isolates (41 MAP and 12 mycobacteria other than MAP), three MAP genomic DNA and 36 MAP faecal DNA samples from different hosts and geographical regions were processed for the investigation of genomic variations using IS1311 PCR-REA and IS1311 L2 PCR-REA. The study was performed between August 2010 and July 2013 at the Department of Microbiology and Molecular Biology, National JALMA Institute for Leprosy and Other Mycobacterial Diseases (NJIL&OMD) located in Agra, Uttar Pradesh, India. Of the 41 MAP isolates, 25, 3, 2 and 11 were from India, Canada, Spain and USA, respectively (Table). Three MAP genomic DNA samples of Portugal origin (provided by Dr Maria Gazouli, School of Animal Science, Agricultural University, Athens, Greece) were also included in this study.
Table

Genotyping of MAP isolates/ DNA using IS1311 PCR-REA and locus 2 specific IS1311 PCR-REA method

Genotyping of MAP isolates/ DNA using IS1311 PCR-REA and locus 2 specific IS1311 PCR-REA method MAP isolates (n=25) and faecal DNA samples (n=36) of Indian origin were collected from epidemiological studies conducted in Agra, Mathura, Jhansi and hilly regions of northern India (data not shown). To check the specificity of IS1311 L2 PCR-REA, a total of 12 mycobacterial isolates other than MAP [M. smegmatis, M. vaccae, M. marinum, M. chelonae, M. flavescens, M.fortuitum, M. kansasii, M. bovis, M. bovis (BCG), M. avium, M.gastri, M. indicus pranii] were obtained from mycobacterial repository, NJIL&OMD, Agra. All the mycobacterial isolates (n=53) were subjected to isolation of genomic DNA as per the method of van Soolingen et al22. DNA samples recovered from isolates and faecal samples were subjected to IS90023, ISMav224 and HspX25 specific PCRs for the molecular identification of MAP. IS1311 PCR-REA (Genotyping of isolates/DNA): Genotyping of each MAP DNA obtained from mycobacterial isolates or faecal samples was carried out by IS1311 PCR-REA method14. Briefly, reaction was carried out in 30 µl volume, containing 20 µl positive IS1311 PCR product, 3 µl 10X buffer (Fermentas, USA), 2 units of each endonuclease HinfI and MseI (Fermentas). Reaction mixture was incubated at 37⁰C for 1.5 h. Band patterns were visualized after electrophoresis on 4 per cent high resolution agarose gel stained with ethidium bromide and genotype profile interpretation was done as described by Sevilla et al14. IS1311 locus 2 PCR-REA (Sub-genotyping of MAP isolates): IS1311 L2 PCR-REA optimized by Sohal et al21 was used to characterize all MAP isolates/faecal DNA included in this study. Firstly, locus 2 of IS1311 was amplified using the specific primers (P1: CACCAACCATGCAGAGGTAA; P2: GGAATCCGCAACTCCAAAT) and then amplicons were subjected to restriction digestion using BsaJ1. PCR reaction mix contained primers (10 pmoles), Taq polymerase (1 unit), MgCl2 (1.5 mM), dNTPs (0.2 mM), buffer 10X (2.5 µl) and template DNA (5 ng) in a final volume of 25.0 µl at thermocycler conditions: denaturation at 95 °C for 5 min followed by 40 cycles of de-naturation at 95 °C for 30 sec, annealing at 55 °C at 30 sec, extension at 72 °C for 1 min followed final extension at 72 °C for 7 min. PCR products were visualized on 1.5 per cent agarose gel. Amplification products (~425 bp) were digested with BsaJI enzyme for 2 h at 37°C and band pattern was observed on 4 per cent agarose gel. The study protocol was approved by the institute's ethical committee.

Results

MAP specific IS900, ISMav 2 and HspX PCRs showed presence of MAP DNA in all samples (Figs. 1–3) except those extracted from isolates of mycobacteria other than MAP.
Fig. 1

Molecular identification of MAP isolates by using PCR targeting IS900 sequence (specific product size 229bp). Lane 1: 100bp marker; Lane 2: Positive control (Indian Bison type MAP S5), Lane 3: Negative control (deionized distilled water); Lane 4: isolates no. T7 (MAP positive); Lane 5: isolates no. 22G (MAP positive); Lane 6: isolates no. R27 (MAP positive); Lane 7: isolates no. MAP 16 (MAP positive); Lane 8: isolates no. MAP 18 (MAP positive), Lane 9: isolates no.W213 (MAP positive).

Fig. 3

Molecular identification of MAP isolates using PCR targeting HspX sequence (Specific product size 211bp). Lane 1: 100bp marker; Lane 2: Negative control (deionized distilled water); Lane 3: Positive control (Indian Bison type MAP S5); Lane 4: isolates no.T7 (MAP positive); Lane 5: isolates no.22G (MAP positive); Lane 6: isolates no. R27 (MAP positive); Lane 7: isolates no. MAP 16 (MAP positive); Lane 8: isolates no. MAP 18 (MAP positive), Lane 9: isolates no.W213 (MAP positive).

Molecular identification of MAP isolates by using PCR targeting IS900 sequence (specific product size 229bp). Lane 1: 100bp marker; Lane 2: Positive control (Indian Bison type MAP S5), Lane 3: Negative control (deionized distilled water); Lane 4: isolates no. T7 (MAP positive); Lane 5: isolates no. 22G (MAP positive); Lane 6: isolates no. R27 (MAP positive); Lane 7: isolates no. MAP 16 (MAP positive); Lane 8: isolates no. MAP 18 (MAP positive), Lane 9: isolates no.W213 (MAP positive). Molecular identification of MAP isolates by using PCR targeting ISMav02 sequence (specific product size 312 bp). Lane 1: 100bp marker; Lane 2: Negative control (deionized distilled water); Lane 3: Positive control (Indian Bison type MAP S5); Lane 4: isolates no.T7 (MAP positive); Lane 5: isolates no.22G (MAP positive); Lane 6: isolates no.R27 (MAP positive); Lane 7: isolates no.MAP 16 (MAP posi-tive); Lane 8: isolates no. MAP 18 (MAP positive), Lane 9: isolates no.W213 (MAP positive). Molecular identification of MAP isolates using PCR targeting HspX sequence (Specific product size 211bp). Lane 1: 100bp marker; Lane 2: Negative control (deionized distilled water); Lane 3: Positive control (Indian Bison type MAP S5); Lane 4: isolates no.T7 (MAP positive); Lane 5: isolates no.22G (MAP positive); Lane 6: isolates no. R27 (MAP positive); Lane 7: isolates no. MAP 16 (MAP positive); Lane 8: isolates no. MAP 18 (MAP positive), Lane 9: isolates no.W213 (MAP positive). IS1311 PCR-REA (Genotyping): Of the 80 MAP-DNA samples, 63, 15 and 2 showed the pattern of ‘Bison type’, ‘Cattle type’ and ‘Sheep type’ genotypes, respectively (Table, Fig. 4). All MAP DNA samples of Indian origin belonged to ‘Bison type’. Of the three isolates of Canada, one each was genotyped as ‘Cattle type’, ‘Sheep type’ and ‘Bison type’. Of the 11 isolates of USA origin, one and 10 were genotyped as ‘Bison type’ and Cattle type, respectively. Of the two isolates from Spain, one was ‘Cattle type’ and another was identified as ‘Sheep type’, whereas, all three isolates of Portugal origin were identified as ‘Cattle type’ (Table).
Fig. 4

Genotyping of MAP isolates using IS1311 polymerase chain reaction-restriction endonuclease analysis. Lane 1: 100bp ladder; Lane 2: isolates no. MAP16 (Bison type of Indian origin); Lane 3: isolates no.429 (Cattle type of Spain origin); Lane 4: isolates no. B1 (Bison type of Canada origin); Lane 5: isolates no.W213 (Cattle type of USA origin); Lane 6: isolates no.22G (Sheep type of Spain origin), Lane 7: isolates no.MAPS1 (Sheep type of Canada origin), Lane 8: 100 bp DNA ladder.

Genotyping of MAP isolates using IS1311 polymerase chain reaction-restriction endonuclease analysis. Lane 1: 100bp ladder; Lane 2: isolates no. MAP16 (Bison type of Indian origin); Lane 3: isolates no.429 (Cattle type of Spain origin); Lane 4: isolates no. B1 (Bison type of Canada origin); Lane 5: isolates no.W213 (Cattle type of USA origin); Lane 6: isolates no.22G (Sheep type of Spain origin), Lane 7: isolates no.MAPS1 (Sheep type of Canada origin), Lane 8: 100 bp DNA ladder. IS1311 L2 PCR-REA (Sub-genotyping): Restriction profile and band pattern for marker IS1311 L2 PCR-REA distinguished ‘Bison type’ DNA of Indian origin from all non-Indian MAP samples (Table, Fig. 5). After restriction digestion of ~425 bp product (belonging to IS1311 element at locus 2) with BsaJI enzyme, four digestion products were visualized in the 4 per cent high resolution agarose gel (34, 67, 78 & 230 bp) for non-Indian MAP. However, digestion of IS1311 locus 2 amplicon of MAP DNA of Indian origin resulted into only three detectable bands in the gel (67, 78 & 262 bp).
Fig. 5

Discriminatory restriction pattern of representative MAP isolates of Indian and non-Indian origin using IS1311 PCR locus 2-REA method. Lane 1 Marker (50bp); Lane 2: Negative control, Lane 3: Undigested PCR product (~425bp); Lane 4: isolates no. W213 (Cattle type of USA origin); Lane 5: isolates no. 22G (Sheep type of Spain origin); Lane 6: isolates no. MAP B1 (Bison type of Canada origin); Lane 7: isolates no. MAP 16 (Bison type of Indian origin); Lane 8: isolates no. MAP 18 (Bison type of Indian origin).

Discriminatory restriction pattern of representative MAP isolates of Indian and non-Indian origin using IS1311 PCR locus 2-REA method. Lane 1 Marker (50bp); Lane 2: Negative control, Lane 3: Undigested PCR product (~425bp); Lane 4: isolates no. W213 (Cattle type of USA origin); Lane 5: isolates no. 22G (Sheep type of Spain origin); Lane 6: isolates no. MAP B1 (Bison type of Canada origin); Lane 7: isolates no. MAP 16 (Bison type of Indian origin); Lane 8: isolates no. MAP 18 (Bison type of Indian origin). On evaluating the specificity of IS1311 L2 PCR-REA on 12 non-MAP mycobacterial DNA, none were amplified except DNA of M. avium. However, the restriction profile of M. avium was different to that of MAP.

Discussion

Molecular epidemiology of MAP has been poorly understood due to slow growth of the pathogen in artificial medium. Rapid strain differentiation methods are pre-requisite to understand the origin of infection, disease transmission and to design disease control strategies. In the present study, IS1311 PCR-REA method was applied on MAP isolates/DNA from India, Canada, USA, Spain and Portugal, and MAP positive faecal DNA samples of domestic ruminants of north India for determining the genotype. Further, potential of recently described IS1311 PCR L2 PCR-REA method was evaluated for genomic marker based differentiation between Indian and non-Indian strains. In the present study, genomic and faecal DNA samples obtained from MAP infected animals of north India were genotyped as Bison type. These results were similar to that reported in previous epidemiological investigations conducted in north India16, and ‘Bison type’ genotype was identified as the dominant genotype. Contrary to the present study, ‘Cattle type’ genotype of MAP was found as predominant genotype infecting domestic livestock, wild ruminant and non-ruminant species in other countries1726. ‘Sheep type’ strains are rarely associated with paratuberculosis in species other than sheep1527. In present study, we could not detect any ‘Cattle type’ and ‘Sheep type’ genotype of MAP in animals from north India. Previously ‘Cattle type’ strains have been reported from cattle and human population of northern India16. The results showed that new IS1311 L2 PCR-REA assay successfully discriminated ‘Bison type’ genotype of Indian origin (’Indian Bison type’) from MAP isolates of other genotypes (Cattle type, Sheep type and Bison type) of non-Indian origin. The test was found to be very specific as all mycobacterial isolates (except M. avium) other than MAP could not be amplified by the MAP specific primers. Due to high genetic similarity between M. avium and MAP, IS1311 L2 PCR amplified the DNA of both. However, the restriction profiles of IS1311 locus 2 by BsaJ1 restriction enzyme were different between both species. The present finding confirmed that ‘TG’ gap deletion at 64th and 65th position of IS1311 element at locus 2 was a stable marker and could be used in future strain typing as ‘Molecular signature’ and in epidemiological investigations. This newly optimized tool successfully worked on the clinical DNA samples obtained from faecal samples of MAP infected animals. Further, this assay can give results much faster (1 day) than culture based typing methods (i.e. RFLP or PFGE) and is particularly suitable in conditions where we may have culture negative results. In conclusion, our study demonstrates that IS1311 L2 PCR-REA assay is a rapid, and easy to perform method for the differentiation of ‘Bison type’ MAP isolates of Indian origin from non-Indian MAP isolates of different genotypes. MAP is an important livestock pathogen world over which besides inviting trade restrictions, is a potential human pathogen.
  22 in total

1.  Typing of IS 1311 polymorphisms confirms that bison (Bison bison) with paratuberculosis in Montana are infected with a strain of Mycobacterium avium subsp. paratuberculosis distinct from that occurring in cattle and other domesticated livestock.

Authors:  R J Whittington; I B Marsh; R H Whitlock
Journal:  Mol Cell Probes       Date:  2001-06       Impact factor: 2.365

Review 2.  Molecular typing of Mycobacterium avium subspecies paratuberculosis strains from different hosts and regions.

Authors:  I x Sevilla; S V Singh; J M Garrido; G Aduriz; S Rodríguez; M V Geijo; R J Whittington; V Saunders; R H Whitlock; R A Juste
Journal:  Rev Sci Tech       Date:  2005-12       Impact factor: 1.181

3.  Detection of Mycobacterium avium subspecies paratuberculosis in free-ranging bison (Bison bison) by PCR.

Authors:  J L E Ellingson; J R Stabel; R P Radcliff; R H Whitlock; J M Miller
Journal:  Mol Cell Probes       Date:  2005-06       Impact factor: 2.365

4.  Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis.

Authors:  D van Soolingen; P W Hermans; P E de Haas; D R Soll; J D van Embden
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

Review 5.  Current understanding of the genetic diversity of Mycobacterium avium subsp. paratuberculosis.

Authors:  Alifiya S Motiwala; Lingling Li; Vivek Kapur; Srinand Sreevatsan
Journal:  Microbes Infect       Date:  2006-01-26       Impact factor: 2.700

6.  Incidence of Mycobacterium paratuberculosis in bulk raw and commercially pasteurized cows' milk from approved dairy processing establishments in the United Kingdom.

Authors:  Irene R Grant; Hywel J Ball; Michael T Rowe
Journal:  Appl Environ Microbiol       Date:  2002-05       Impact factor: 4.792

7.  Use of highly specific DNA probes and the polymerase chain reaction to detect Mycobacterium paratuberculosis in Johne's disease.

Authors:  P H Vary; P R Andersen; E Green; J Hermon-Taylor; J J McFadden
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

8.  Mycobacterium paratuberculosis infection in a colony of stumptail macaques (Macaca arctoides).

Authors:  H M McClure; R J Chiodini; D C Anderson; R B Swenson; W R Thayer; J A Coutu
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

9.  Efficacy of commercial and field-strain Mycobacterium paratuberculosis vaccinations with recombinant IL-12 in a bovine experimental infection model.

Authors:  Jude E Uzonna; Paula Chilton; Robert H Whitlock; Perry L Habecker; Phillip Scott; Raymond W Sweeney
Journal:  Vaccine       Date:  2003-07-04       Impact factor: 3.641

10.  Isolation of Mycobacterium avium subspecies paratuberculosis from Ugandan cattle and strain differentiation using optimised DNA typing techniques.

Authors:  Julius Boniface Okuni; Chrysostomos I Dovas; Panayiotis Loukopoulos; Ilias G Bouzalas; David Patrick Kateete; Moses L Joloba; Lonzy Ojok
Journal:  BMC Vet Res       Date:  2012-06-29       Impact factor: 2.741

View more
  3 in total

1.  Concurrent Resolution of Chronic Diarrhea Likely Due to Crohn's Disease and Infection with Mycobacterium avium paratuberculosis.

Authors:  Shoor V Singh; J Todd Kuenstner; William C Davis; Prabhat Agarwal; Naveen Kumar; Devendra Singh; Saurabh Gupta; Kundan K Chaubey; Ashok Kumar; Jyoti Misri; Sujatha Jayaraman; Jagdip S Sohal; Kuldeep Dhama
Journal:  Front Med (Lausanne)       Date:  2016-10-27

2.  Characteristics and Epidemiological Investigation of Paratuberculosis in Dairy Cattle in Tai'an, China.

Authors:  Zilong Cheng; Mengda Liu; Peng Wang; Peng Liu; Meng Chen; Jiandong Zhang; Sidang Liu; Fangkun Wang
Journal:  Biomed Res Int       Date:  2020-03-13       Impact factor: 3.411

3.  First molecular typing of Mycobacterium avium subspecies paratuberculosis identified in animal and human drinking water from dairy goat farms in Brazil.

Authors:  Isis F Espeschit; Marina C C Souza; Magna C Lima; Maria A S Moreira
Journal:  Braz J Microbiol       Date:  2017-10-12       Impact factor: 2.476

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.